X0303 4 2010-11-09 0 0001363851 SXC Health Solutions Corp. SXCI 0001334925 Thierer Mark 2441 WARRENVILLE ROAD SUITE 610 LISLE IL 60532 0 1 0 0 President & CEO Common share 2010-11-09 4 M 0 78304 7.7982 A 129634 D Common share 2010-11-09 4 S 0 35258 37.533 D 94376 D Common share 2010-11-09 4 S 0 43046 38.6165 D 51330 D Common share 2010-11-10 4 M 0 31696 7.7943 A 83026 D Common share 2010-11-10 4 M 0 13704 11.79 A 96730 D Common share 2010-11-10 4 S 0 45400 37.0649 D 51330 D Common share 2010-11-11 4 M 0 89848 11.79 A 141178 D Common share 2010-11-11 4 S 0 85798 37.7682 D 55380 D Common share 2010-11-11 4 S 0 4050 38.0102 D 51330 D Stock option (nonqualified) 11.79 2010-11-10 4 M 0 13704 0.00 D 2012-05-16 Common share 13704 286296 D Stock option (nonqualified) 11.79 2010-11-11 4 M 0 89848 0.00 D 2012-05-16 Common share 89848 196448 D Stock option (nonqualified) 7.815 2010-11-09 4 M 0 67000 0.00 D Common share 67000 31696 D Stock option (nonqualified) 7.815 2010-11-10 4 M 0 31696 0.00 D Common share 31696 0 D Stock option (nonqualified) 7.815 2010-11-09 4 M 0 11304 0.00 D Common share 11304 98696 D Exercised and/or sold pursuant to Insider's 10b5-1 plan. Converted from Cdn. $7.815 using an average exchange rate of 1.00216 On September 17, 2010, the common stock of SXC Health Solutions, Inc. split 2-for-1, resulting in the reporting person's acquisition of 25,665 additional shares of common stock. Prices for transactions reported range from $37.04 to $38.03. Full information regarding the number of shares purchased or sold at each separate price will be provided upon request by the Commission staff, the issuer, or a security holder of the issuer. Prices for transactions reported range from $38.04 to $38.95. Full information regarding the number of shares purchased or sold at each separate price will be provided upon request by the Commission staff, the issuer, or a security holder of the issuer. Converted from Cdn. $7.815 using an average exchange rate of 1.00266 Prices for transactions reported range from $36.60 to $37.52. Full information regarding the number of shares purchased or sold at each separate price will be provided upon request by the Commission staff, the issuer, or a security holder of the issuer. Prices for transactions reported range from $37.00 to $37.995. Full information regarding the number of shares purchased or sold at each separate price will be provided upon request by the Commission staff, the issuer, or a security holder of the issuer. Prices for transactions reported range from $38.00 to $38.02. Full information regarding the number of shares purchased or sold at each separate price will be provided upon request by the Commission staff, the issuer, or a security holder of the issuer. This option was previously reported as covering 6,852 shares at an exercise price of $23.58 per share, but was adjusted to reflect the stock split on September 17, 2010. This option was granted 5/16/07 and vests in one-fourth increments on each grant date anniversary. This option was previously reported as covering 44,924 shares at an exercise price of $23.58 per share, but was adjusted to reflect the stock split on September 17, 2010. This option was previously reported as covering 33,500 shares at an exercise price of C$15.63 per share, but was adjusted to reflect the stock split on September 17, 2010. This option was granted on 8/28/06 and vested or will vest, as the case may be, in one-third increments on each of 12/31/06, 12/31/07 and 12/31/08. Each vested increment expires five years from the respective vest date. This option was previously reported as covering 15,848 shares at an exercise price of C$15.63 per share, but was adjusted to reflect the stock split on September 17, 2010. This option was granted on 8/28/06 and vests in one-fourth increments on each grant date anniversary. Each vested increment expires five years from the respective vest date. This option was previously reported as covering 5,652 shares at an exercise price of C$15.63 per share, but was adjusted to reflect the stock split on September 17, 2010. Mark Thierer, BY: Stacey Martinez, his attorney-in-fact 2010-11-11